Implementation of the Patient Counselling Service at the Cancer Hospital in Radom, Poland
Katarzyna Grzyb,
Martyna Meresińska,
Urszula Religioni (),
Grzegorz Juszczyk,
Jakub Płaczek,
Agnieszka Neumann-Podczaska,
Filip M. Szymański,
Beata Chełstowska,
Katarzyna Wieczorowska-Tobis,
Szczepan Cofta,
Sławomir Tobis,
Rafał Staszewski,
Regis Vaillancourt,
Rafał Majewski,
Justyna Hernik,
Katarina Fehir Sola,
Eliza Blicharska,
Justyna Kaźmierczak,
Ewa Rutkowska,
Elżbieta Prygiel,
Monika Skierska,
Monika Nawara,
Izabela Korbiewska,
Jerzy Krysiński and
Piotr Merks
Additional contact information
Katarzyna Grzyb: Radom Oncology Center im, Bohaterów Radomskiego Czerwca 76′, 26-600 Radom, Poland
Martyna Meresińska: Department of Pharmaceutical Technology, Faculty of Pharmacy, Collegium Medicum in Bydgoszcz, 85-089 Bydgoszcz, Poland
Urszula Religioni: School of Public Health, Centre of Postgraduate Medical Education of Warsaw, Kleczewska 61/63, 01-826 Warsaw, Poland
Grzegorz Juszczyk: Department of Public Health, Medical University of Warsaw, 02-097 Warsaw, Poland
Jakub Płaczek: Department of Pharmaceutical Technology, Faculty of Pharmacy, Collegium Medicum in Bydgoszcz, 85-089 Bydgoszcz, Poland
Agnieszka Neumann-Podczaska: Department of Palliative Medicine, Poznan University of Medical Sciences, 61-245 Poznan, Poland
Filip M. Szymański: Department of Civilization Diseases, Faculty of Medicine, Collegium Medicum, Cardinal Stefan Wyszynski University in Warsaw, 01-938 Warsaw, Poland
Beata Chełstowska: Department of Biochemistry and Laboratory Diagnostics, Faculty of Medicine, Collegium Medicum, Cardinal Stefan Wyszynski University in Warsaw, 01-938 Warsaw, Poland
Katarzyna Wieczorowska-Tobis: Department of Palliative Medicine, Poznan University of Medical Sciences, 61-245 Poznan, Poland
Szczepan Cofta: Heliodor Swiecicki Clinical Hospital in Poznan, 60-355 Poznan, Poland
Sławomir Tobis: Department of Pulmonology, Allergology and Respiratory Oncology, Poznan University of Medical Sciences, 60-569 Poznan, Poland
Rafał Staszewski: Department of Hypertension, Angiology and Internal Medicine, Poznan University of Medical Sciences, 61-848 Poznań, Poland
Regis Vaillancourt: Department of Pharmacology and Clinical Pharmacology, Faculty of Medicine, Collegium Medicum, Cardinal Stefan Wyszynski University in Warsaw, 01-938 Warszawa, Poland
Rafał Majewski: Radom Oncology Center im, Bohaterów Radomskiego Czerwca 76′, 26-600 Radom, Poland
Justyna Hernik: Radom Oncology Center im, Bohaterów Radomskiego Czerwca 76′, 26-600 Radom, Poland
Katarina Fehir Sola: Pharmacy of Bjelovar, Petra Preradovića, 43000 Bjelovar, Croatia
Eliza Blicharska: Department of Analytical Chemistry, Medical University of Lublin, Chodźki 4a, 20-093 Lublin, Poland
Justyna Kaźmierczak: Zdrowit sp. z o.o., Pharmacy Chain, 41-940 Piekary Śląskie, Poland
Ewa Rutkowska: Radom Oncology Center im, Bohaterów Radomskiego Czerwca 76′, 26-600 Radom, Poland
Elżbieta Prygiel: Radom Oncology Center im, Bohaterów Radomskiego Czerwca 76′, 26-600 Radom, Poland
Monika Skierska: Radom Oncology Center im, Bohaterów Radomskiego Czerwca 76′, 26-600 Radom, Poland
Monika Nawara: Radom Oncology Center im, Bohaterów Radomskiego Czerwca 76′, 26-600 Radom, Poland
Izabela Korbiewska: Rehabilitation Faculty of Medical Sciences, Medical University of Warsaw, Żwirki i Wigury 61, 02-091 Warsaw, Poland
Jerzy Krysiński: Department of Pharmaceutical Technology, Faculty of Pharmacy, Collegium Medicum in Bydgoszcz, 85-089 Bydgoszcz, Poland
Piotr Merks: Department of Pharmacology and Clinical Pharmacology, Faculty of Medicine, Collegium Medicum, Cardinal Stefan Wyszynski University in Warsaw, 01-938 Warszawa, Poland
IJERPH, 2022, vol. 19, issue 20, 1-9
Abstract:
Background: Non-adherence occurs in various groups of patients, including those with chronic diseases. One strategy to increase adherence among oncological patients is to individualise treatment and expand pharmaceutical care. Pharmaceutical labels that remind patients how they should take their medications are of great importance in this respect. Objective: The main objective of this study was to evaluate medication adherence in oncological patients, and to gather their opinions on the individual medication labelling system as an element of effective treatment. Methods: The study was conducted in 2021 among 82 patients of the oncological department of the Centre of Oncology in Radom. The research tool was a questionnaire consisting of personal data and two parts relating to the patient’s disease and the medication labelling system. Results: Nearly half of the respondents reported that they forget to take medications and how they should take them. These problems increased with the age of the patient and the number of administered medications. Of the respondents, 89% stated that the labels with dosing information are helpful. Over 67% agreed that these labels should be affixed to all medications. Nearly 90% of the respondents believed the labels should be available in all pharmacies. Conclusions: Non-adherence is a common phenomenon among oncological patients. Pharmacists providing a labelling service for medicinal products can play a significant role in reducing this phenomenon.
Keywords: chronic disease; cancer; oncology; hospital pharmacy; pharmacist; adherence (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2022
References: View references in EconPapers View complete reference list from CitEc
Citations:
Downloads: (external link)
https://www.mdpi.com/1660-4601/19/20/13642/pdf (application/pdf)
https://www.mdpi.com/1660-4601/19/20/13642/ (text/html)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:19:y:2022:i:20:p:13642-:d:948970
Access Statistics for this article
IJERPH is currently edited by Ms. Jenna Liu
More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().